Results 61 to 70 of about 830,673 (331)

What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up [PDF]

, 2010
Background: During the last two decades, resection of colorectal liver metastases (CLM) in selected patients has become the standard of care, with 5-year survival rates of 25-58%.
Parks, Rowan W.; id_orcid, Aldrighetti, Luca, Garden, O. James, Parks, Rowan W., Bodingbauer, Martin, Wigmore, Stephen J., Castillo, Federico, Ferla, Gianfranco, Pulitano, Carlo   +8 more
core   +1 more source

AIF1+CSF1R+ MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis

Hepatology, EarlyView., 2022
Mesenchymal stem cells subset, educated by TNF‐α, are involved to generate inflammatory microenvironment and promote hepatocarcinogenesis Abstract Background and Aims Increasing evidence suggests that mesenchymal stem cells (MSCs) home to injured local tissues and the tumor microenvironment in the liver.
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei   +9 more
wiley   +1 more source

Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report

Surgical Case Reports, 2020
Background Despite recent advances in systemic chemotherapy, the prognosis of patients with peritoneal metastases from gastric cancer still remains poor.
Kozo Miyatani, Wataru Miyauchi, Yusuke Kono, Yuji Shishido, Joji Watanabe, Takehiko Hanaki, Kyoichi Kihara, Tomoyuki Matsunaga, Manabu Yamamoto, Yoji Fukumoto, Naruo Tokuyasu, Shuichi Takano, Teruhisa Sakamoto, Soichiro Honjo, Toshimichi Hasegawa, Yoshiyuki Fujiwara   +15 more
doaj   +1 more source

The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review.

Journal of Gastrointestinal Oncology, 2021
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an emerging palliative treatment for patients with unresectable peritoneal metastases. Potential advantages of PIPAC over current treatment options are a homogeneous intraperitoneal distribution,
R. Lurvink, K. van der Speeten, K. Rovers, I. D. de Hingh   +3 more
semanticscholar   +1 more source

Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: Two case reports [PDF]

, 2008
Background: With the current improvements in primary lung care, the long-term control of brain metastases becomes a clinical challenge. No established therapeutic approaches exist for cranial relapse after response to previous radiotherapy and systemic ...
Pawel, Joachim, Wagner, Horst, Poellinger, Barbara, Duell, Thomas   +3 more
core   +1 more source

Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis

Scientific Reports, 2021
The usefulness of local collagenase in therapeutic approaches to solid tumors has been tested recently. In this study, we evaluate the safety and efficacy of intraperitoneal collagenase associated or not to mitomycin for treatment of colorectal ...
D. García-Olmo, P. Villarejo Campos, J. Barambio, S. Garcia Gomez-Heras, L. Vega-Clemente, S. Olmedillas-Lopez, H. Guadalajara, M. Garcia-Arranz   +7 more
doaj   +1 more source

Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases

bioRxiv
Peritoneal metastases (PM) in gastric cancer (GC) portend a poor prognosis, yet our understanding of tumor microenvironmental (TME) characteristics associated with GCPM remain limited.
Joseph J. Zhao, Chin-Ann Johnny Ong, Supriya Srivatsava, Daryl Kai Ann Chia, Haoran Ma, K. Huang, T. Sheng, Kalpana Ramnarayanan, X. Ong, S. Tay, T. Hagihara, Angie Lay Keng Tan, Melissa Ching Ching Teo, Q. Tan, Gillian Ng, Joey Wee-Shan Tan, Matthew Chau Hsien Ng, Y. X. Gwee, Robert Walsh, Jia-Hao Law, Asim Shabbir, Guowei Kim, Yvonne Tay, Z. Her, G. Leoncini, B. Teh, J. Hong, Ryan Yong Kiat Tay, Chong-Bo-On Teo, M. P. Dings, M. Bijlsma, Jeffrey Huey Yew Lum, Sachin Mathur, F. Pietrantonio, Steven M Blum, H. V. van Laarhoven, S. Klempner, W. Yong, Jimmy Bok Yan So, Qing-Feng Chen, P. Tan, R. Sundar   +41 more
semanticscholar   +1 more source

Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM

European Radiology
Diagnostic imaging of peritoneal metastases in ovarian and colorectal cancer remains pivotal in selecting the most appropriate treatment and balancing clinical benefit with treatment-related morbidity and mortality.
V. Vandecaveye, Pascal Rousset, S. Nougaret, A. Stepanyan, M. Otero-García, Olivera Nikolić, M. Hameed, K. Goffin, I. D. de Hingh, M. Lahaye   +9 more
semanticscholar   +1 more source

[Comment] Risk of metachronous peritoneal metastases after surgery for obstructive colon cancer: multivariate analysis from a series of 1,085 patients

结直肠肛门外科
[Background] Data in the literature suggest that obstruction is an independent predictor of poor prognosis in colon cancer. Of all possible sites of recurrence, peritoneal metastases are associated with worse survival. Our aim was to report the incidence
Yu Liang, Huang Shenghui
doaj   +1 more source

Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?

Current Issues in Pharmacy and Medical Sciences, 2017
The gastric cancer with peritoneal metastases still represents a serious problem in the oncological surgery, whereas the peritoneal metastases arising from colorectal cancer can be successfully treated using a multimodal therapy concept consisting of ...
Blaj Sebastian, Piso Pompiliu
doaj   +1 more source